Pegasus Materials
Bio-based specialty polymers (Virela-X001 polyamide, Virela-X002 polyimide) engineered for high-performance industrial 3D printing, electronics, and aerospace applications with lower environmental footprint.
- CEO / Founder
- Richard Pieters
- Team Size
- 1-10
- Stage
- Active
- Latest Round
- Seed
- Key Investors
- LIOF (NV Industriebank LIOF); Fibrant; Ferment
Technology & Products
Key Products
Virela-X001 (bio-based high-heat polyamide for precision-molded connectors and electronics); Virela-X002 (partially bio-based polyimide for industrial additive manufacturing)
Technological Advantage
Proprietary bio-based chemistry platform that addresses performance requirements (higher thermal tolerance, better electrical properties, superior mechanical strength) while using renewable sources; synthetic biology approach enables rapid custom polymer iteration; partnership-based manufacturing model reduces capex.
Differentiation
Value Proposition
Delivers high-performance bio-based alternatives to conventional polymers, enabling thinner walls, better electrical properties, superior thermal tolerance, and reduced manufacturing defects while maintaining sustainability credentials and renewable sourcing.
How They Differentiate
Bio-based renewable sourcing (lower greenhouse gas emissions) combined with industrial-grade performance specifications; AI/ML-driven custom polymer design capability; lightweight manufacturing enablement (thinner walls, higher yields) for electronics and aerospace.
Market & Competition
Target Customers
Electronics manufacturers, aerospace OEMs, data center operators, precision-molded connector producers
Industry Verticals
Electronics; Aerospace; 3D Printing/Additive Manufacturing; Electric Vehicles; Data Centers
Growth & Milestones
Growth Metrics
Specialty polymers market valued at $75B with high growth; company positioned in underserved innovation segment within high-growth market. Announced expansion of Seed round and launch of first two commercial products (Virela-X001, Virela-X002) as of Q4 2025.
Major Milestones
Announced Seed funding expansion with Ferment and renewed LIOF support; Launched first two bio-based specialty materials (Virela-X001 and Virela-X002); Secured manufacturing partnerships for commercial scale-up